Search

everythinglearnresearchcommunity

for

Search:↓

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Alcohol extract from Vernonia anthelmintica seeds may help treat stress-related hair loss.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

Hair and scalp disorders significantly affect self-esteem, and using cosmetic products like conditioners and styling aids can improve hair health and appearance.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Scientists can mimic hair disorders by altering genes in lab-grown human hair follicles, but these follicles lack some features of natural ones.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document is a detailed medical reference on skin and genetic disorders.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common side effect of hormone treatments for cancer.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.